Sign in Request a demo
Solutions / Overview

Outcomes for every
commercial & medical team.

Six purpose-built solutions, all sharing the same evidence layer. Choose the ones you need today, they compose into a single source of truth for tomorrow.

01

Strategy & Forecasting

Bayesian launch & lifecycle.

02

HCP Engagement

Next-best-action for field.

03

Market Access

Live formulary & PA.

04

Competitive Intelligence

MoA-clustered radar.

05

Medical Affairs

KOL & evidence strategy.

06

Real-World Evidence

RWD-grade cohorts.

01 / 06

Strategy & Forecasting

Replace months of consulting with a workspace that produces defensible launch curves in days. Patient flow, switching, payer & provider levers, all editable, all auditable.

  • Top-down and bottom-up models reconciled in one view
  • Pre-built priors for 40+ TAs · editable assumptions library
  • Excel + PowerPoint export with live source links
See it on your TA
02 / 06

HCP Engagement

Give every rep, MSL and digital channel a live picture of which physician to engage, with what message, and why, drawn from real prescribing dynamics.

  • Decile-aware targeting with switching propensity scores
  • Next-best-content from your approved promotional library
  • Veeva, Salesforce and OCE bi-directional sync
03 / 06

Market Access

Live coverage, PA criteria and rebate intelligence across US PBMs and EU HTAs. Know what changed this week, who's affected, and what your team should do about it.

  • Coverage tier and PA criteria for 4,200+ commercial & gov plans
  • Net-price modeling with rebate scenarios and GTN impact
  • Weekly diff reports — the access changes that matter
04 / 06

Competitive Intelligence

Trial readouts, label changes and conference disclosures clustered by mechanism, indication and care setting, with weekly briefings written by px-copilot.

  • 240+ source feeds · trials, labels, posters, transcripts
  • Auto-grouped by MoA and indication for at-a-glance scanning
  • Weekly briefings · Slack & email delivery
05 / 06

Medical Affairs

Map evidence gaps, identify KOLs by sub-specialty, and co-author publication strategy with px-copilot, every recommendation backed by a citation graph.

  • KOL discovery by mechanism, indication and care setting
  • Evidence-gap analysis with publication priorities
  • Congress planning · MSL workflows
06 / 06

Real-World Evidence

Production-grade RWD cohorts, treatment-pattern analyses and outcomes, built on validated, audit-ready pipelines.

  • Pre-validated cohort templates across 30+ disease areas
  • Treatment-pattern, persistence and outcomes endpoints
  • 21 CFR Part 11 audit trails · regulatory-grade output

Start with one. Compose the rest.

Pick the solution closest to your urgent question. The others light up when you're ready.

Talk to us